Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
about
Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsLipidomic profiling of model organisms and the world's major pathogensAntioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewTargeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengersEndothelial dysfunction: a comprehensive appraisal.Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureThe inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice.Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice.Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health StudyImplication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages.Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolaseLipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitusGenotype x adiposity interaction linkage analyses reveal a locus on chromosome 1 for lipoprotein-associated phospholipase A2, a marker of inflammation and oxidative stressPatients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbits.Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.PLAC test for identification of individuals at increased risk for coronary heart disease.The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorderClinical importance and therapeutic modulation of small dense low-density lipoprotein particles.Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional studyLipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.Standardization of a method to evaluate the antioxidant capacity of high-density lipoproteins.Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution.Correlation between plasma lipoprotein-associated phospholipase A2 and peripheral arterial disease.Effects of eprosartan on serum metabolic parameters in patients with essential hypertension.Usefulness of self-reported periodontal disease to identify individuals with elevated inflammatory markers at risk of cardiovascular diseaseRelationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals.Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.HDL and cholesterol: life after the divorce?Lipoprotein-associated phospholipase A₂ mass level is increased in elderly subjects with type 2 diabetes mellitus.From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.High-density lipoprotein and atherosclerosis: the role of antioxidant activity.Inflammatory markers in coronary artery disease.The underlying chemistry of electronegative LDL's atherogenicity.
P2860
Q26747100-3457A8CB-39DE-4499-8CE9-AA22287A0CB8Q26777871-A7623916-072B-4B41-988B-179868058C38Q26822690-BA797255-4580-43E9-8361-D4C80BCD0FF4Q26991853-C3E52C67-B4AC-4E35-B36C-2822B60C1947Q27008183-9552834B-8686-4C6A-B0BA-C0C17FC6557BQ28195411-E377B693-D97E-474D-82C7-186E6FDE5600Q33536648-3F63C5E4-36E0-4C91-84D8-6BFA1D65E99EQ33566165-CFAF079E-57E1-41E6-896C-C3FCA66A28E1Q33866072-2A7FC58A-6F4F-4FCA-90D3-B47486C90578Q33895897-387E7F35-5EC0-4E32-8E62-D805E3968CC2Q33993219-A1228361-F40E-40A3-B123-F230E33C1240Q34541071-FACF34CF-6385-446C-A388-7AE7153E9204Q34670677-D48F319D-1864-41AD-8607-F39E0AFD9942Q35520145-71AEE997-E10F-4C17-A488-E74B60345549Q35616553-CB600354-BEE9-45E9-8321-DD49BEE2D700Q35769101-18BD1B9F-A320-47F2-9127-D0234476071EQ35925371-A26170B4-A2BB-4584-8422-A0588BEEB98BQ36024430-034107C7-4168-4359-B4A0-A09A0AD68A8FQ36050527-49169DFF-F057-4312-9804-A8DBCE1C1233Q36105683-3E3FC719-CD5C-415F-ADD7-5915697BD62AQ36145180-187C8CD7-12E0-4626-9C17-318C471FC245Q36651524-BF30E676-8D7E-4DEA-BE7B-27B3AEA86D16Q36675450-B8D0EBAC-A2C1-4A22-A13D-DFC97AB6CEB6Q36707842-4A4BE5A1-6A2F-4425-9169-44C81374802EQ36723319-4F0FC009-E559-44F3-867B-A3F0B07B12DDQ36735598-9B3EB2E7-2360-4D99-839C-571D7789C246Q36899258-3C21A2D1-06FD-40E2-B6ED-0437EB40CA6CQ36900840-4EDA7F87-0653-41E7-996F-6BD7973F9C48Q36944124-48F4327B-C5D9-49B9-80D2-57D19CBD2714Q37092510-2DB27C4C-56CD-41D1-B4DD-96D64C0F4B40Q37299885-58384560-132A-4F9E-BF27-684CFAD1D9F3Q37430645-CA0E0507-4173-43B7-9B6C-0B4CC58007D0Q37433102-D295CCA5-2727-42E9-B2BC-11BC5072517BQ37445865-3E8BF4F6-C594-4322-A9C4-F77F4E4048E1Q37590250-5C33CAA5-15C1-4C8A-BA37-22E15577D89DQ37730748-2EB9F958-6F1A-468A-AA6A-11216F8F01F7Q37881966-9E01A61B-1EA2-4E9D-B7BA-312AD55D0A9BQ37996363-55B55561-D4BF-4B6E-94DF-0319CFD74E7AQ38013061-F12321C4-E40B-46F7-8D45-EDE729CE64A9Q38217088-CE4126CB-F90A-4B44-B45C-63C778F025E4
P2860
Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@ast
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@en
type
label
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@ast
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@en
prefLabel
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@ast
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@en
P1476
Inflammation, bioactive lipids ...... vating factor-acetylhydrolase.
@en
P2093
Alexandros D Tselepis
M John Chapman
P356
10.1016/S1567-5688(02)00045-4
P577
2002-12-01T00:00:00Z